Mc Farlane Neil F. Insider Trades

Insider Trading History

Track insider trading activity for Mc Farlane Neil F.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Zevra Therapeutics
Zevra Therapeutics ZVRA
President And CEO
Holding Value $4.33M 387,225 shares
Last Trade
Feb 09, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$125k 14,625 shares
$8.56
$11.17
Zevra Therapeutics
Zevra Therapeutics ZVRA
President And CEO
Holding Value $4.49M 401,850 shares
Last Trade
Feb 07, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$323k 37,500 shares
$8.60
$11.17
Zevra Therapeutics
Zevra Therapeutics ZVRA
President And CEO
Holding Value $838k 75,000 shares
Last Trade
Feb 07, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$323k 37,500 shares
$8.60
$11.17
Zevra Therapeutics
Zevra Therapeutics ZVRA
President And CEO
Holding Value $4.07M 364,350 shares
Last Trade
Feb 02, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$854k 91,000 shares
$9.38
$11.17
Zevra Therapeutics
Zevra Therapeutics ZVRA
President And CEO
Holding Value $2.61M 233,333 shares
Last Trade
Jan 31, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.1M 233,334 shares
$9.00
$11.17
Zevra Therapeutics
Zevra Therapeutics ZVRA
President And CEO
Holding Value $5.09M 455,350 shares
Last Trade
Jan 31, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.1M 233,334 shares
$9.00
$11.17
Zevra Therapeutics
Zevra Therapeutics ZVRA
President And CEO
Holding Value $1.4M 125,000 shares
Last Trade
Jan 29, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.09M 125,000 shares
$8.74
$11.17
Zevra Therapeutics
Zevra Therapeutics ZVRA
President And CEO
Holding Value $2.79M 250,000 shares
Last Trade
Jan 29, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.22M 250,000 shares
$8.86
$11.17
Adamas Pharmaceuticals
Adamas Pharmaceuticals ADMS
Chief Executive Officer
Holding Value $2.06M 250,000 shares
Last Trade
Sep 16, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.56M 250,000 shares
$6.25
$8.22
Adamas Pharmaceuticals
Adamas Pharmaceuticals ADMS
Chief Executive Officer
Holding Value $1.03M 125,000 shares
Last Trade
Sep 16, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$781k 125,000 shares
$6.25
$8.22
Travere Therapeutics
Travere Therapeutics TVTX
Chief Operating Officer
Holding Value $1.25M 26,988 shares
Last Trade
May 16, 2019 Sale (Open Market)Shares sold on the open market or in a private sale.
$18.4k 984 shares
$18.71
$46.18
Travere Therapeutics
Travere Therapeutics TVTX
Chief Operating Officer
Holding Value $1.29M 27,972 shares
Last Trade
May 15, 2019 Sale (Open Market)Shares sold on the open market or in a private sale.
$17.5k 984 shares
$17.78
$46.18
Travere Therapeutics
Travere Therapeutics TVTX
Chief Operating Officer
Holding Value $1.34M 28,956 shares
Last Trade
Dec 20, 2018 Sale (Open Market)Shares sold on the open market or in a private sale.
$144k 6,404 shares
$22.56
$46.18
Travere Therapeutics
Travere Therapeutics TVTX
Chief Operating Officer
Holding Value $1.63M 35,360 shares
Last Trade
Dec 20, 2018 Sale (Open Market)Shares sold on the open market or in a private sale.
$104k 4,721 shares
$22.00
$46.18
Travere Therapeutics
Travere Therapeutics TVTX
Chief Operating Officer
Holding Value $1.85M 40,081 shares
Last Trade
Dec 18, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$253k 11,125 shares
$22.71
$46.18
Travere Therapeutics
Travere Therapeutics TVTX
Chief Operating Officer
Holding Value $1.36M 29,476 shares
Last Trade
Nov 14, 2018 Sale (Open Market)Shares sold on the open market or in a private sale.
$213k 9,000 shares
$23.63
$46.18
Travere Therapeutics
Travere Therapeutics TVTX
Chief Operating Officer
Holding Value $1.32M 28,476 shares
Last Trade
Nov 14, 2018 Sale (Open Market)Shares sold on the open market or in a private sale.
$24.6k 1,000 shares
$24.64
$46.18
Travere Therapeutics
Travere Therapeutics TVTX
Chief Operating Officer
Holding Value $1.78M 38,476 shares
Last Trade
Nov 09, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$258k 10,000 shares
$25.77
$46.18
Travere Therapeutics
Travere Therapeutics TVTX
Chief Operating Officer
Holding Value $1.29M 27,948 shares
Last Trade
May 10, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$265k 10,500 shares
$25.25
$46.18
Travere Therapeutics
Travere Therapeutics TVTX
Chief Operating Officer
Holding Value $485k 10,500 shares
Last Trade
May 10, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$265k 10,500 shares
$25.25
$46.18

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up